News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Lettmann Jason
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2020 |
4
| Lettmann Jason (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns:
| Converted 88,704 shares
@ $0 Converted 1,831,027 shares
@ $0 Converted 249,632 shares
@ $0 Bought 378,000 shares
@ $19, valued at
$7.2M
Converted 1,498,984 shares
@ $0 Bought 22,000 shares
@ $19, valued at
$418k
Converted 111,528 shares
@ $0 Converted 78,175 convertible preferred
@ $0 Converted 1,633,743 convertible preferred
@ $0 Converted 222,752 convertible preferred
@ $0 Converted 683,523 convertible preferred
@ $0 |
|
07/17/2020 |
4
| Lettmann Jason (10% Owner) has filed a Form 4 on ALX ONCOLOGY HOLDINGS INC
Txns:
| Granted 24,009 options to buy
@ $19, valued at
$456.2k
|
|
07/16/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/22/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
10/31/2016 |
4
| Lettmann Jason (Director) has filed a Form 4 on Ra Pharmaceuticals, Inc.
Txns:
| Exercised (in-or-at-the-money) 63,019 shares
@ $0.07, valued at
$4.4k
Sold 340 shares
@ $13, valued at
$4.4k
Converted 1,392,130 shares
@ $0 Converted 523,438 shares
@ $0 Converted 486,919 shares
@ $0 Converted 542,702 shares
@ $0 Converted 73,945 shares
@ $0 Converted 504,839 shares
@ $0 Converted 68,786 shares
@ $0 Bought 263,538 shares
@ $13, valued at
$3.4M
Bought 114,752 shares
@ $13, valued at
$1.5M
|
|
10/25/2016 |
3
| Form 3 - Initial statement of beneficial ownership of securities |
|
|